At the 10th Annual Clinical Cancer Genetics & Genomics Conference Haibo Lu and Matt Valin presented the challenges of high-risk cancer program design.
The CancerIQ product suite is an end-to-end solution, genetic history data gathering to supporting the management of high-risk care plans.
CancerIQ joined leading experts in breast health at the National Consortium of Breast Centers’ 31st Annual Interdisciplinary Breast Center...
Dr. Olopade shared the promise of precision health to transform cancer outcomes for the better — so long as key informatics challenges can be...
As the nation honors Black History Month and National Cancer Prevention Month, experts are calling attention to disparities in screening access and...
2021 prompted us to define the “new normal” in every facet of our lives, and cancer care was no exception.
Millions of women with a family history of breast or ovarian cancer have yet to undergo genetic testing despite lifetime risk being 7x higher than...
Health systems with top-tier high-risk breast program increase early detection, prevent costly late-stage cancer care, and improve survival rates.
At HIMSS21, AHEAD Medical Director Candace Westgate, DO, explained how technology helped Adventist Health bring genomics to patients systemwide.
NCBC 2021: Breast centers expedited the adoption of virtual care to better serve high-risk patients missing appointments due to COVID-19.